Lynch, James T <br/><br/>
Inhibiting PI3Kβ with AZD8186 Regulates Key Metabolic Pathways in PTEN-Null Tumors.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Dec 2017 
 - 7584-7595 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-17-0676  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aniline Compounds--administration & dosage<br/>Animals<br/>Cell Line, Tumor<br/>Chromones--administration & dosage<br/>Class II Phosphatidylinositol 3-Kinases--genetics<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Hydroxymethylglutaryl-CoA Synthase--genetics<br/>Metabolic Networks and Pathways--genetics<br/>Mice<br/>PTEN Phosphohydrolase--genetics<br/>Triple Negative Breast Neoplasms--drug therapy<br/>Xenograft Model Antitumor Assays